L-CYSTEINE-N-FMOC, S-TRITYL (13C3,15N) is an Fmoc-protected cysteine derivative bearing a trityl (S-trityl) thioether protection on the side-chain sulfur and isotopic enrichment at the cysteine backbone (13C3,15N). The molecule contains an Fmoc carbamate on the amino group and a free carboxyl group, with the sulfur substituent functioning as a protected thiol equivalent that can be deprotected during peptide assembly while maintaining chemoselectivity toward the side chain. In peptide chemistry and chemical biology workflows, it is employed as a labeled, stepwise building block for solid-phase or solution-phase synthesis of cysteine-containing peptides and for preparing isotopically tagged analogues used in structural characterization, analytical method development, or labeling-based studies.
CAT No: L-Iso-0195
1. Implications of ligand-receptor binding kinetics on GLP-1R signalling
2. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.